Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C, Chronic, Healthy Volunteer”

36 trials

Showing 20 of 36 results

Early research (Phase 1)Study completedNCT03430830
What this trial is testing

Evaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China

Who this might be right for
Chronic Hepatitis c
Ascletis Pharmaceuticals Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT00382798
What this trial is testing

Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin

Who this might be right for
Healthy VolunteersHepatitis C Virus
Pharmasset 75
Early research (Phase 1)Study completedNCT01371162
What this trial is testing

RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic, Healthy Volunteer
Hoffmann-La Roche 42
Early research (Phase 1)Study completedNCT01907724
What this trial is testing

Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and Ritonavir When Administered in Combination in Healthy Participants (MK-1894-007)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 34
Early research (Phase 1)Study completedNCT00314054
What this trial is testing

Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults

Who this might be right for
Hepatitis CHepatic Insufficiency
Wyeth is now a wholly owned subsidiary of Pfizer 27
Early research (Phase 1)Study completedNCT01296451
What this trial is testing

Study of a New MVA Vaccine for Hepatitis C Virus

Who this might be right for
Hepatitis C Infection
ReiThera Srl 55
Early research (Phase 1)Study completedNCT00359463
What this trial is testing

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 33
Early research (Phase 1)Ended earlyNCT02510248
What this trial is testing

First in Human Study of AL-704; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C

Who this might be right for
Chronic Hepatitits C
Alios Biopharma Inc. 42
Early research (Phase 1)Study completedNCT01211626
What this trial is testing

Study of ANA773 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) to Assess Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)

Who this might be right for
HCV Infection
Hoffmann-La Roche 75
Early research (Phase 1)Study completedNCT04232514
What this trial is testing

Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects

Who this might be right for
Chronic Hepatitis C
Sunshine Lake Pharma Co., Ltd. 28
Early research (Phase 1)Study completedNCT01202825
What this trial is testing

TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected Patients

Who this might be right for
Hepatitis C
Tibotec Pharmaceuticals, Ireland 72
Early research (Phase 1)Study completedNCT02063607
What this trial is testing

The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients

Who this might be right for
Hepatitis C
Nanogen Pharmaceutical Biotechnology Joint Stock Company 60
Early research (Phase 1)Ended earlyNCT03253471
What this trial is testing

A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Alios Biopharma Inc. 24
Testing effectiveness (Phase 2)WithdrawnNCT04309734
What this trial is testing

Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects

Who this might be right for
Hepatitis CHepatitis C, ChronicChronic Hepatitis C+2 more
Atea Pharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT01181024
What this trial is testing

A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic, Healthy Volunteer
Hoffmann-La Roche 82
Early research (Phase 1)Ended earlyNCT01554085
What this trial is testing

First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Alios Biopharma Inc. 78
Early research (Phase 1)Study completedNCT01813513
What this trial is testing

Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004)

Who this might be right for
Chronic Hepatitis C Infection
Merck Sharp & Dohme LLC 42
Early research (Phase 1)Study completedNCT02512562
What this trial is testing

Evaluate the Effect of ACH-3102 and Simeprevir on AL-335 Pharmacokinetics in Healthy Volunteers

Who this might be right for
Chronic Hepatitis C
Alios Biopharma Inc. 32
Testing effectiveness (Phase 2)Ended earlyNCT00229749
What this trial is testing

Study of AVI-4065 in Healthy Volunteers and Chronic Active HCV Patients

Who this might be right for
Hepatitis C
Sarepta Therapeutics, Inc. 80
Early research (Phase 1)Study completedNCT01889849
What this trial is testing

Comparative Pharmacokinetics and Pharmacodynamics of Peginterferon BIP48 and 40kDa in Healthy Volunteers

Who this might be right for
Chronic Viral Hepatitis C
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 32
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation